期刊文献+

硫脲类抗甲状腺药物的安全性问题 被引量:15

Safety issues of thiourea antithyroid drugs
原文传递
导出
摘要 硫脲类抗甲状腺药物具有抑制甲状腺激素生成的作用,临床上用于治疗甲状腺功能亢进症。常见的硫脲类抗甲状腺药物有丙硫氧嘧啶和甲巯咪唑。其不良反应包括药疹、粒细胞缺乏症、严重肝损伤、抗中性粒细胞胞质抗体(ANCA)相关性血管炎等,并有一定的致畸作用。严重肝损伤和ANCA相关性血管炎的发生多与丙硫氧嘧啶有关,致畸作用主要见于甲巯咪唑。儿童和非妊娠期甲状腺功能亢进症患者的治疗首选甲巯咪唑,妊娠和哺乳期患者首选丙硫氧嘧啶。防治硫脲类抗甲状腺药物不良反应的措施包括:合理用药、定期监测、出现不良反应及时停药,以及对症治疗。 Thiourea antithyroid drugs have an inhibitory effect on the production of thyroid hormone and are used in the treatment of hyperthyroidism in clinical practice.The commonly used thiourea antithyroid drugs are methimazole and propylthiouracil.Their adverse reactions include drug eruption,agranulocytosis,serious hepatic injures,ANCA-associated vasculitis and teratogenicity. Severe hepatic injures and ANCA-associated vasculitis are mainly related to propylthiouracil,while teratogenicity is caused by methimazole.Methimazole is a first-choice drug for treating children and non-pregnant women with hyperthyroidism,while propylthiouracil is a first-choice drug for treating pregnant and breast-feeding women.The measures of the prevention and treatment of adverse reactions to thiourea antithyroid drugs are as follows:rational drug use,regular monitoring,drug withdrawl immediately after developing related adverse reactions and treatment.
作者 连小兰
出处 《药物不良反应杂志》 2011年第4期232-235,共4页 Adverse Drug Reactions Journal
关键词 硫脲类抗甲状腺药物 安全性 thiourea antithyroid drugs safety
  • 相关文献

参考文献24

  • 1Cooper DS.Antithyroid drugs[J].N Engl JMed,2005,352(9):905-917.
  • 2Nakamura H,Noh JY,Itoh K,et al.Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease[J].J Clin Endocrinol Metab,2007,92(6):2157-2162.
  • 3Chang CC,Huang ST.Is traditional chinese medicine effective for reducing hyperthyroidism?[J].J Altern Complement Med,2010,16(11):1217-1220.
  • 4Pearce EN,Braverman LE.Hyperthyroidism:advantages and disadvantages of medical therapy[J].Surg Clin North Am,2004,84 (3):833-847.
  • 5Sun MT,Tsai CH,Shih KC.Antithyroid drug-induced agranulocytosis[J].J Chin Med Assoc,2009,72 (8):438-441.
  • 6Tajiri J,Noguchi S.Antithyroid drug-induced agranulocytosis:how has granulocyte colony-stimulating factor changed therapy?[J].Thyroid,2005,15(3):292-297.
  • 7Andrès E,Kurtz JE,Maloisel F.Nonchemotherapy druginduced agranulocytosis:experience of the Strasbourg teaching hospital (1985-2000) and review of the literature[J].Clin Lab Haematol,2002,24(2):99-106.
  • 8连小兰,白耀,戴为信,郭芝生,李伟,卢琳.丙基硫氧嘧啶治疗甲状腺功能亢进症引起显著性肝损伤[J].中国医学科学院学报,2004,26(2):172-177. 被引量:13
  • 9Zhang M,Zhou H,He R,et al.Steroids for the treatment of methimazole-induced severe cholestatic jaundice in a 74-year-old woman with type 2 diabetes[J].Endocrine,2010,37(2):241-243.
  • 10Shen C,Zhao CY,Liu F,et al.Acute-on-chronic liver failure due to thiamazole in a patient with hyperthyroidism and trilogy of Fallot:case report[J].BMC Gastroenterol,2010,10:93.

二级参考文献18

  • 1Benichou C. Criteria of drug-induced liver disorders: Report of an international consensus meeting. J Hepatol, 1990,11:272-276
  • 2Williams KV, Nayak S, Becker D, et al. Fifty years of experience with propylthiouracil-associated hepatotoxicity:what have we learned? J Clin Endocrinol Metab, 1997,82:1727-1733
  • 3Gurlek A, Cobaukara V, Bayraktar M. Liver tests in hyperthyroidism: effect of antithyroid therapy. J Clin Gastroenterol, 1997, 24:180-183
  • 4Liaw YF, Huang MJ, Fan KD, et al. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intern Med, 1993, 118:424-428
  • 5Kim HJ, Kim BH, Han YS, et al. The incidence and clinical characteristics of symptomatic propylthiouracilinduced hepatic injury in patients with hyperthyroidism: a single-center retrospective study. Am J Gastroenterol, 2001,96:165-169
  • 6Huang MJ, Li KL, Wei JS, et al. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study. Am J Gastroenterol, 1994, 89:1071-1076
  • 7Lock DR, Sthoeger ZM. Severe hepatotoxicity on beginning propylthiouracil therapy. J Clin Gastroenterol, 1997, 24:267-269
  • 8Ozenirler S, Tuncer C, BoztePe U, et al. Propylthiouracilinduced hepatic damage. Ann Pharmacother, 1996, 30:960-963
  • 9Liaw YF, Huang MJ, Fan KD, et al. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intern Med,1993,118:424-428.
  • 10Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol,1990,11:272-276.

共引文献33

同被引文献132

引证文献15

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部